20/20 BioResponse is an American bioweapons testing service based in Rockville, Maryland. It is a division of 20/20 GeneSystems.
On March 19, 2020, the company issued a press release announcing the launch of its CoronaCheck COVID-19 Rapid Antibody Test Kit.[1]
Baker, R. (2020, March 19). 20/20 BioResponse to Launch Rapid Coronavirus Test Kits in U.S. following “Green Light” from FDA. BioSpace. http://archive.today/2020.03.20-222805/https://www.biospace.com/article/releases/20-20-bioresponse-to-launch-rapid-coronavirus-test-kits-in-u-s-following-green-light-from-fda/ ↩︎